Embrace Change Acquisition Corp Warrants

NASDAQ:EMCGW USA Shell Companies
Market Cap
$149.62
Market Cap Rank
#43332 Global
#13881 in USA
Share Price
$0.02
Change (1 day)
-50.00%
52-Week Range
$0.01 - $0.05
All Time High
$0.10
About

Embrace Change Acquisition Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in San Diego, California.

Embrace Change Acquisition Corp Warrants (EMCGW) - Net Assets

Latest net assets as of June 2025: $20.08 Million USD

Based on the latest financial reports, Embrace Change Acquisition Corp Warrants (EMCGW) has net assets worth $20.08 Million USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($26.82 Million) and total liabilities ($6.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $20.08 Million
% of Total Assets 74.84%
Annual Growth Rate 875.87%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 160646.86

Embrace Change Acquisition Corp Warrants - Net Assets Trend (2021–2024)

This chart illustrates how Embrace Change Acquisition Corp Warrants's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Embrace Change Acquisition Corp Warrants (2021–2024)

The table below shows the annual net assets of Embrace Change Acquisition Corp Warrants from 2021 to 2024.

Year Net Assets Change
2024-12-31 $20.26 Million -61.12%
2023-12-31 $52.12 Million -29.76%
2022-12-31 $74.20 Million +340738.02%
2021-12-31 $21.77K --

Equity Component Analysis

This analysis shows how different components contribute to Embrace Change Acquisition Corp Warrants's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 582092300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $26.09 Million 128.74%
Total Equity $20.26 Million 100.00%

Embrace Change Acquisition Corp Warrants Competitors by Market Cap

The table below lists competitors of Embrace Change Acquisition Corp Warrants ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Embrace Change Acquisition Corp Warrants's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 52,116,956 to 20,263,286, a change of -31,853,670 (-61.1%).
  • Net income of 1,443,000 contributed positively to equity growth.
  • Share repurchases of 33,296,263 reduced equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $1.44 Million +7.12%
Share Repurchases $33.30 Million -164.32%
Other Changes $-407.00 -0.0%
Total Change $- -61.12%

Book Value vs Market Value Analysis

This analysis compares Embrace Change Acquisition Corp Warrants's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.00x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 6.68x to 0.00x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 $0.00 $0.02 x
2022-12-31 $15.15 $0.02 x
2023-12-31 $7.02 $0.02 x
2024-12-31 $3.18 $0.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Embrace Change Acquisition Corp Warrants utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 7.12%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.29x
  • Recent ROE (7.12%) is above the historical average (4.11%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2022 0.55% 0.00% 0.00x 1.04x $-7.01 Million
2023 4.65% 0.00% 0.00x 1.08x $-2.79 Million
2024 7.12% 0.00% 0.00x 1.29x $-583.33K

Industry Comparison

This section compares Embrace Change Acquisition Corp Warrants's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Embrace Change Acquisition Corp Warrants (EMCGW) $20.08 Million 0.55% 0.34x $27.11K
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K